gpt-dict.com

螺內酯 / 安達通 Spironolactone × 多毛症

結論：證據支持但有警示

螺內酯治療多毛症為 OFF-LABEL 用藥（FDA/EMA/TFDA 核准適應症皆限於心衰竭、高血壓、肝硬化腹水、原發性醛固酮過多症），但獲 Endocrine Society 2018 臨床指引明文推薦（100-200 mg/日分次給藥）並有 Cochrane 2009 SR、JCEM 2018 網絡統合分析等多項 SR/MA 證實效力顯著優於安慰劑（OR 7.

A 🔵 A 中度證據 附警語發布 ✨ low — community discussion mostly non-commercial
⚠️ 標記 🇹🇼 台灣在地警示

螺內酯治療多毛症為 OFF-LABEL 用藥（FDA/EMA/TFDA 核准適應症皆限於心衰竭、高血壓、肝硬化腹水、原發性醛固酮過多症），但獲 Endocrine Society 2018 臨床指引明文推薦（100-200 mg/日分次給藥）並有 Cochrane 2009 SR、JCEM 2018 網絡統合分析等多項 SR/MA 證實效力顯著優於安慰劑（OR 7.18, 95% CI 1.96-26.28），與 finasteride、flutamide 相當。

因屬 off-label 且需療程 ≥6 個月、孕期禁忌、需監測高血鉀，無法給 A，但具備一線指引推薦+多項 SR/MA 證據，符合 B 級標準。

⚖️

評分透明度

所有分數由 7 層證據引擎計算，過程公開可查
原始分數 0.71
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
A · 附警語發布
信心度
89%
證據方向一致性高
證據層級
E1
Cochrane 高品質系統性回顧／統合分析

各層「支持此療效」的程度

分數越低＝該層越不支持
L1 Examine國際基準
0.50
L5 臨床機構權威立場
0.60
L11 AI 複核獨立判讀
0.65
L3 機轉生理合理性
0.75
L2 PubMed原始文獻
0.85
不支持 中性 / 混合 支持
▸查看完整決策路徑（audit trail）
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.708
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標，未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
PMID: 19370553 2009 Cochrane SR
— 詳細結論請見 PubMed 原文
前往 PubMed
Treatment Options for Hirsutism: A Systematic Review and Network Meta-Analysis
PMID: 29522176 2018 Network Meta-analysis
— 詳細結論請見 PubMed 原文
前往 PubMed
Antiandrogens for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
PMID: 18252786 2008 統合分析
— 詳細結論請見 PubMed 原文
前往 PubMed
Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More than an Anti-androgen? Evidence from a Systematic Review and Meta-analysis
PMID: 36999713 2023 統合分析
— 詳細結論請見 PubMed 原文
前往 PubMed
Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne (original Cochrane)
PMID: 14583916 2003 Cochrane SR
— 詳細結論請見 PubMed 原文
前往 PubMed

L4a US FDA
支持
Spironolactone has been shown to be a tumorigen in chronic toxicity studies in rats. Spironolactone should be used only in those conditions described under INDICATIONS AND USAGE. Unnecessary use of this drug should be avoided. ALDACTONE is indicated for: Treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hosp… 來源↗
L4b EU EFSA
支持
Qaialdo received marketing authorization on 26 May 2023. It is authorized to manage refractory oedema associated with congestive heart failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, and for diagnosis and treatment of primary aldosteronism and essential hypertension. The medicine can only be obtained with a prescription, and children should only be tre… 來源↗
L4c UK NHS
支持
It's used to treat: swelling, in the ankles, feet and other parts of the body, caused by fluid build-up (oedema), heart failure, high blood pressure (hypertension) if other medicines have not worked. It's only available with a prescription. Spironolactone is not usually recommended during pregnancy. This is because it can potentially affect a baby's development. [Serious side effects include] h… 來源↗
L4d TW TFDA / 衛福部
支持
安達通錠25 毫克 Aldactone Tablets 25 mg 衛署藥輸字第022610號 本藥須由醫師處方使用。適應症：利尿、高血壓、原發性醛類脂醇過多症。孕婦用藥分級：D 級。高血鉀症徵象(有高達26%病人發生，即使與Thiazide 利尿劑合用亦如此)。 來源↗
L4e WHO
支持
Spironolactone is an aldosterone receptor antagonist used to treat edema, hypertension, heart failure, and aldosteronism. More specifically, its antimineralocorticoid activity is responsible for its therapeutic efficacy in the treatment of edema, high blood pressure, heart failure, hyperaldosteronism, and ascites due to cirrhosis. Additionally, spironolactone reduces the rate of testosterone pr… 來源↗

L5a NIH Office of Dietary Supplements
支持
Spironolactone tablets are indicated for: (1) the treatment of NYHA Class III-IV heart failure and reduced ejection fraction to increase survival, manage edema, and to reduce the need for hospitalization for heart failure, and (2) use as an add-on therapy for the treatment of hypertension, to lower blood pressure. Additionally, spironolactone is indicated for the management of edema in adult pa… 來源↗
L5b Mayo Clinic
謹慎
The most commonly used anti-androgen for hirsutism treatment is spironolactone (Aldactone, CaroSpir). The results are modest and take at least six months to be seen. Side effects can include irregular periods. These medicines also can cause birth defects, so it's important to use birth control while you take them. 來源↗
L5c Cleveland Clinic
支持
These medications, including spironolactone (Aldactone®), finasteride (Proscar®) and flutamide (Eulexin®), can effectively treat mild cases of hirsutism by lowering the amount of androgens your body produces. 來源↗
L5d Harvard Health
支持
The most commonly used medicine is spironolactone (Aldactone), although others are available. It is unsafe to take anti-androgen medicines during pregnancy. 來源↗
L5e Specialty Society (condition-mapped)
謹慎
For most women with hirsutism, we suggest against antiandrogen monotherapy as initial therapy (because of the teratogenic potential of these medications) unless these women use adequate contraception. Spironolactone 100-200 mg/d given in divided doses (twice daily). We do not suggest one antiandrogen over another. 來源↗

PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 低度
低中高
📍立場總覽

TW 社群（PTT/Dcard/Mobile01）對「螺內酯（安達通 / Aldactone）治療多毛症」的直接討論非常少；多數討論集中在多囊（PCOS）與女性雄性禿（FPHL），且多由部落格、醫療衛教站轉述，而非使用者親身體毛改善心得。屬於 OFF-LABEL（FDA 核准適應症為高血壓、心衰、腹水；多毛症為仿單外使用）。社群口碑偏向「臨床上可用、但效果緩慢、需 6 個月以上」、副作用以月經紊亂、乳房脹痛、頭暈、高血鉀為主，需處方且需定期追蹤血鉀。

💬社群實感

資料不足

破解迷思 社群最常見的 5 個誤解
✓
事實誤以為螺內酯（安達通）是減肥藥或單純利尿劑，忽略其抗雄性激素效果
✓
事實誤以為短期 1–2 個月就能見到體毛變細，實際需 6 個月以上
✓
事實誤以為螺內酯與口服避孕藥效果相同，可任意替換（實際多為合併使用）
✓
事實誤以為自行買得到，實際為處方藥，需婦產科或皮膚科開立
✓
事實誤以為螺內酯只用在脫髮，不知也用於多毛症與荷爾蒙痘
🩹 社群通報的副作用
  • 月經週期紊亂、經血量改變
  • 乳房脹痛、乳房腫大
  • 高血鉀（需定期抽血追蹤）
  • 頭暈、姿勢性低血壓、頻尿
  • 腸胃不適（噁心、腹痛）
🏷️ 社群熱議品牌

依論壇被提及頻率，非銷售或品質排序。

  • 安達通 Aldactone（Pfizer，台灣最常見原廠）
  • 愛達信錠 Aldactone 25mg（安泰醫院藥訊提及）
  • Spiractin（部分藥局可調劑）
  • 丰生 / 台廠螺內酯學名藥
  • 台大醫院藥劑部 / 奇美醫院（衛教資訊來源）
  • 皮膚科 / 婦產科處方（非藥局自費購買）

⚠️ 列出僅代表「TW 社群討論度高」，不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

安達通錠25 毫克 Aldactone Tablets 25 mg 衛署藥輸字第022610號 本藥須由醫師處方使用

代表來源 ↗
L10b · TFDA 法定身份 官方認定
💊藥品（須醫師處方／指示）

安達通錠25 毫克 Aldactone Tablets 25 mg 衛署藥輸字第022610號 本藥須由醫師處方使用

來源 ↗

  • 口服避孕藥 (含抗雄激素 progestin)
  • Spironolactone 50-200 mg/d
✓ PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 5 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v3 engine_version: v1.0 claim_id: CLM-COND-hirsutism-INT-spironolactone-001
查看 ClaimReview 結構化資料 (JSON-LD) 
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-hirsutism-INT-spironolactone-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "螺內酯 / 安達通能改善多毛症",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 4,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🔵 A 中度證據"
  }
}